Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients

Author:

Xing Xiaofang123ORCID,Guo Jianping4,Ding Guangyu1,Li Bo5,Dong Bin6,Feng Qin6,Li Shen7,Zhang Jian8,Ying Xiaomin8,Cheng Xiaojing1,Guo Ting1,Du Hong1,Hu Ying2,Zhou Tao9,Wang Xiaohong2,Li Lin1,Li Qingda1,Xie Meng1,Li Liting1,Gao Xiangyu1,Shan Fei7,Li Ziyu7,Jia Shuqin3,Wen Xianzi1,Wang Jiping10,Ji Jiafu16723

Affiliation:

1. Department of Gastrointestinal Translational Research, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, Beijing, China

2. Tissue Bank, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, Beijing, China

3. Department of Molecular Diagnosis, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, Beijing, China

4. Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

5. Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA, USA

6. Department of Pathology, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, Beijing, China

7. Department of Gastrointestinal Surgery, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, Beijing, China

8. Computational Omics Laboratory, Center of Computational Biology, Beijing Institute of Basic Medical Sciences, Beijing, Beijing, China

9. State Key Laboratory of Proteomics, Institute of Basic Medical Sciences, National Center of Biomedical Analysis, Beijing, Beijing, China

10. Division of Surgical Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

Funder

National High technology Research and Development Program of China

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3